×

Goals of care: a clinical framework for limitation of medical treatment

The development of clear, effective and consistent clinical processes for decision making relating to limitations of medical treatment and documentation of the decisions is an ongoing challenge for all health care systems.

We propose a clinical framework called “goals of care” (GOC). This approach has been introduced and audited in two Australian health services (Royal Hobart Hospital, Tasmanian Health Organisation — South, and Northern Health, Melbourne, Victoria) and is being considered elsewhere. It is influenced by the Physician Orders for Life Sustaining Treatment approach (http://www.polst.org), which is widely used in the United States, coupled with the innovation of assigning each patient episode to one of three treatment categories based on the overall medical treatment goals for that patient at that time.

The three-phase model

Medical decision making is based on determining the GOC for the patient. The patient’s situation is assigned to one of three phases of care according to a realistic assessment of the probable outcomes of medical treatment. These phases are clinically defined intentional categories that take heed of, but are quite distinct from, personal goals expressed by patients. Patients can move from one category to another during their illness trajectory. The phases are curative or restorative, palliative, and terminal;1 they are based on phases that were first described in 1990.2 The distinguishing features of each phase are shown in the Box.

The patient assessment is shared with the patient or substitute decisionmaker (SDM) and, if agreed, a GOC plan form is completed and placed in the alerts section of the patient’s medical record. A GOC plan is a medical order that clarifies limitations of medical treatment for a present condition; it is not the same as an advance directive, which is usually made by a person, in his or her own “voice”, to inform medical decision making for future episodes of impaired capacity. Goals are revised in the light of changes in medical condition, and appropriate limitations are then documented on a new form. A GOC plan replaces institutional or community-based not-for-resuscitation (NFR) orders.

We documented GOC plans using an original form (Appendix 1), which has been used at Royal Hobart Hospital for the past 3 years. A second, revised form (Appendix 2) is now being introduced more widely in Tasmania, after extensive experience and feedback from clinicians, medical records staff and others. It is simpler and has been modified for use in all settings, including homes and nursing homes.

The original developmental work was done in Hobart after the Royal Hobart Hospital completed a Respecting Patient Choices pilot site project in 2008. This project put a sharp focus on decision making at the end of life across the whole hospital community.

In 2010, a project officer position was created to enable the development of GOC as part of a statewide Healthy Dying Initiative. Based on the principles of health-promoting palliative care, this initiative aimed to empower the whole community, including the health sector, to deal with death in a more direct, open and therefore “healthy” way. Clinical decision making at the end of life was identified as a priority for policy and procedural reform. There were three initial components of the Healthy Dying Initiative: GOC, advance directive redesign and promotion, and encouragement of health-promoting activities relating to death and dying.

The project officer, a non-clinician with extensive experience in community development, helped design the GOC form, develop the policy protocol for its implementation and use, launch the new form, and facilitate initial training in individual hospital units. GOC education was then done jointly with the advance directive work in the wider community in collaboration with a designated officer in the Office of the Chief Health Officer, Department of Health and Human Services, Tasmania.

Audit results

On 1 March 2011, the GOC form and protocol came into effect at Royal Hobart Hospital; it replaced the NFR procedure and form, which were withdrawn with effect from that date.

A retrospective audit of admissions to the Assessment and Planning Unit during August 2011 was undertaken. It showed that GOC forms had been completed for 75% of admitted patients (135/181). A retrospective audit of admissions to the Assessment and Planning Unit during August 2009, before introduction of GOC, showed that NFR forms had been completed for 34% of admitted patients (55/162). (These data were compiled on 28 September 2009 and 26 September 2011, respectively.)

On 6 September 2012, a 1-day point prevalence audit of GOC form completion was undertaken throughout Royal Hobart Hospital, excluding paediatric and day-stay patients. Patient records were reviewed for the presence of a GOC form and/or other relevant documents, such as an advance directive. GOC forms had been completed for 52% of inpatients (148/283) and for 85% of medical inpatients (124/146) who had been admitted that day. For non-medical admissions, a GOC form was completed for 21% of patients (24/112). All 18 patients who subsequently died had dying recognised (GOC category D), and half of them received input from the palliative care service.

A GOC form was implemented at Northern Health on 12 August 2013. It was adapted from the version used at Royal Hobart Hospital, using input from Northern Health clinicians. It was mandated for all adult medical inpatients and for selected surgical patients. A 1-day point prevalence audit of medical patients on 17 November 2013 showed that treatment goals were completed for 81% of patients (82/101).7

Discussion

The purpose of GOC is to ensure that patients who are unlikely to benefit from medical treatment aimed at cure receive care appropriate to their condition and are not subjected to burdensome or futile treatments, particularly cardiopulmonary resuscitation and medical emergency team calls, especially when these are, or may be, contrary to their wishes.

One of the aims of GOC is to change the culture of medical decision making. GOC takes on the challenges of “prognostic paralysis” and the “no-surprises approach”,4 diagnosing dying,8 and prognostic uncertainty.9 There is evidence that many decisions to limit treatment occur in crisis situations, particularly during medical emergency team calls.10 Difficult decisions therefore tend to be made after hours, in the heat of the moment, by clinicians who do not know the patient and without patient or SDM input. GOC prompts treating teams to proactively determine treatment goals at a time when the assessment is likely to be of higher quality and discussions with the patient and family are easier to arrange.

Screening all patients on admission helps identify those who wish to decline treatments that might otherwise be given to them (particularly relevant for treatments that involve blood products). Those who are fit and otherwise well can be screened with the question “are there any treatments that you do not wish to have?”. Others, in light of their past history and current presentation, will require a more in-depth conversation that balances their hopes and expectations with what is medically achievable.

The default position for all patients is the curative or restorative phase, and all appropriate life-prolonging treatment should be deployed as indicated until it is clear that the clinical situation has changed. In other words, the default always favours preservation of life. It has become evident that there is an important subpopulation of patients for whom the goal is cure or restoration but specific limitations of medical treatment apply because of patient wishes or beliefs, and this is specifically articulated in GOC category B on the new Tasmanian form (Appendix 2).

GOC relies on high-quality clinical assessment and good communication skills. Most importantly, it requires clinicians to make a decision. While challenging and contested, differentiation between the palliative and terminal phases is essential. There is a large difference in the medical management and care of a person who has a potential prognosis of a year or two (eg, a patient who has incurable bone metastases due to prostate or breast cancer) and that for a person who may not survive a week.

There are many pertinent observations that can be used to diagnose dying, which can be divided into four principal domains: (i) disease activity; (ii) general functioning; (iii) specific clinical parameters; and (iv) evidence of “death talk” by patients and families. In combination, these observations can help to show whether death is anticipated within the next few days and allow a change of GOC to the terminal phase. Most of the evidence so far suggests that simple non-medical general function parameters are most predictive of impending death.11 For patients in the terminal phase, deployment of tools based on the Liverpool Care Pathway for the Dying Patient (LCP) may be considered. There has been positive experience of an LCP-type tool in Australia,12 despite some negative experiences associated with use of the LCP in the United Kingdom, for which the LCP has, perhaps unfairly, been blamed.13,14

If the diagnosis of dying is made too early and a patient’s condition unexpectedly stabilises, he or she will live on provided that the care implemented is proportionate and matched to symptoms, according to principles presented, for example, to the Senate of Canada by the Chief Coroner of Ontario in 1997.15 There are often oscillations in patient condition as the terminal phase approaches, but, once patients are deemed to be in the terminal phase, it is unusual for them to sustainably “upgrade” back to the earlier palliative phase.

The GOC process has proved to be safe, effective and widely acceptable for addressing the limitation of medical treatment in two Australian health services that encompass large acute tertiary hospitals, with aged care and related subacute services. Feedback from clinical staff has been positive, and compliance is variable but rising. So far, there have been no reported major incidents or complaints in which GOC has been causally implicated in an adverse outcome. Comparison with the NFR era is difficult as the population denominator now consists of all admitted patients, not just those deemed unsuitable for resuscitation.

Regular review at each patient encounter is important, with changes to GOC phase and/or treatment limitations as warranted by patient wishes or condition. A clear need was identified at an early stage of the initial GOC project to ensure that limitations determined and documented during an acute admission could be continued during ambulance transfers and within homes, nursing homes and other facilities. An arbitrary 90-day endorsement validity limit was initially stipulated, but this has been removed as it was found to be unnecessary and confusing. General practitioners and community nurses were also keen to see GOC initiated in the community setting, especially for palliative care clients, and this has informed the design of the new Tasmanian form (Appendix 2).

In a recent report, the Australian Commission on Safety and Quality in Health Care acknowledged that it is necessary to attempt to reverse acute clinical deterioration but also to recognise dying and deploy appropriate palliative and terminal care.16

There were extensive discussions about patients or SDMs being required to sign the GOC form to confirm adequate consultation and agreement. The developers have resisted this, arguing that it is a medical form to direct care, and not a patient directive. The emphasis should be on a process of medical assessment and communication that ideally results in clear patient agreement, and/or consensus with the SDM and those who care for and about the person concerned, regarding any limitations of medical treatment.

A requirement for SDMs to sign a GOC form might engender guilt by conveying a false concern about the locus of responsibility for causing death. It should, however, be clear that the doctor signing the form (on behalf of the medical specialist in charge) is taking responsibility for the clinical decision and all appropriate consultation with patients or their agents, as required by ethics and law.17 Ultimately, the decision about signature requirements will lie with individual institutions and/or jurisdictions that start using GOC. Similarly, the distinction between consent and receipt of information will need to be made clear by individual institutions.

We recommend that all health care providers consider replacing their NFR procedures with the GOC approach. GOC is a solid framework for limiting medical treatment that meets the challenge for medical leadership to address the culture of death avoidance in medical decision making.17,18 It also has the potential to help address widespread professional and public concerns about bad dying. Rigorous ongoing “postmarketing” surveillance, auditing and research are, of course, necessary to ensure patient safety and transparency of process.

The three-phase model of goals of care (GOC)

 

1. Curative or restorative phase (“beating it”)

2. Palliative phase (“living with disease, anticipating death”)

3. Terminal phase (“dying very soon”)


 

The default position for all patients — all appropriate life-prolonging treatment will be deployed as indicated (Categories A and B in our forms)

The disease is deemed to be incurable and progressive (Category C in our forms)

Death is believed to be imminent (ie, within a few days) — implementation of a terminal care pathway, where available, is indicated (Category D in our forms)

Aim

 

GOC are directed towards cure, prolonged disease remission and/or restoration to the pre-episode health status for those with chronic diseases, especially in the aged care context

GOC are modified in favour of comfort, quality of life and dignity; period of survival is no longer the sole determinant of treatment choice; life prolongation is a secondary objective of medical treatment, although palliative care might confer modest survival benefits, as shown in two lung cancer studies3

Comfort, quality of life and dignity are the only considerations

Prognosis

 

Life expectancy is probably indefinite (ie, normal) because the present health episode is unlikely to affect longevity; a key question could be “is there a reasonable chance of the patient leaving hospital and living the same life span as might have been expected before the episode?”; a key question in aged care and chronic disease settings (where the goals might be restorative) could be “is there a reasonable chance of the patient leaving hospital and/or returning to his or her previous level of functioning?”

Life expectancy is usually months, but sometimes years (if the latter is the case, “supportive care” might be a more appropriate term than “palliative care”, and patients might choose to have active treatment of disease until disease response ceases); a key question could be “would I/we be surprised if this patient died in the next 12 months?”4

Life expectancy is hours or days; a key question could be “would I/we be surprised if this patient died this week?”

Level of adverse effects

 

A high level of adverse effects and even a significant chance of treatment-related mortality might be accepted for curative treatment (eg, brain aneurysm surgery, bone marrow transplant); while pain and symptom control should always be addressed, comfort may be a secondary consideration if it conflicts with curative treatment

Active treatment of the underlying disease may be undertaken for specific symptoms (eg, radiotherapy or chemotherapy for palliative end point in cancer treatment) and/or short-term life expectancy gains; treatment-related adverse effects should be proportionate to the goals and acceptable to the patient

Active treatment of the underlying disease should stop; no treatment-related toxicity is acceptable (this applies to all medical, nursing and allied health interventions [eg, turns in bed if these are distressing])

Life-sustaining treatments

 

Given as needed

Life-sustaining treatments for other chronic medical conditions are usually continued (eg, treatment with insulin or anticonvulsants) in cases where cessation would result in premature death or preventable unpleasant symptoms such as hyperglycaemia and seizures (ie, symptoms unrelated to the main disease that is anticipated to cause death) or where quality of life would be adversely affected5

Life-sustaining treatments for other chronic medical conditions are usually stopped (eg, treatment with steroids, insulin or anticonvulsants), unless doing so would cause suffering

Medical provision of hydration and alimentation

 

Given as needed

Given if indicated and desired (eg, percutaneous endoscopic gastrostomy feeding for head and neck cancer patients with obstructed swallowing)

Usually ceased and replaced with feeding on request and rigorous mouth care

Cardiopulmonary resuscitation

 

Given as needed

Usually not recommended but should be discussed with the patient, if competent; if death and dying have already been explicitly discussed with the patient or person responsible, specific discussion of cardiopulmonary resuscitation might not be warranted6

Contraindicated

Use of advance directives by South Australians: results from the Health Omnibus Survey Spring 2012

Advance directives (ADs) have been championed as a remedy for providing evidence of the medical, financial, health care and lifestyle options a person would choose at a time when they may lack capacity for decision making.1 A review of the literature in this area found that these instruments can be useful, but are not widely used due to a variety of factors which inhibit their effectiveness.1,2 In Australia, barriers to effective completion of ADs include poor understanding and application of the different AD forms.2 There is a lack of actual published data on completion rates of specific types of ADs used in Australia.2 As primary care involves assessing individuals at increased risk of chronic diseases and hospital care, low rates of completion of ADs in particular age or other demographic groups may suggest the potential for AD completion initiatives led by general practitioners. This would, in turn, lead to better outcomes from a primary health care, patient management and family carer perspective.

The aim of this study was to determine the proportion of South Australians who have completed the medical, financial, health care or lifestyle ADs in South Australia and/or a will (an instrument often believed to be an AD2). Demographic variables associated with completion or non-completion of these instruments were also investigated.

Methods

Data were collected through the South Australian Health Omnibus Survey (HOS) from 5200 households selected for interview between 4 September and 12 December (spring) 2012. The HOS included a non-replacement sample of people aged 15 years or older. Participants in the spring 2012 survey had an age range of 15 to 97 years. Complete methods for the HOS have been described in detail elsewhere.3 In brief, a random stratified sampling technique was used, defined by a random starting point with 10 households sampled per collection district using a fixed-skip interval. Data were stratified by sex (male/female), age (18–24, 25–34, 35–44, 45–54, 55–64 and ≥ 65 years) and area of residence (metropolitan/rural/regional). In non-metropolitan locations, samples were self-weighting. A cluster size of 10 households was also used for each of the 130 collection districts. Data were weighted by the inverse of the individual’s probability of selection as well as by the response rate in metropolitan and country regions, then reweighted to benchmarks derived from the 2011 estimated resident population based on the 2011 Census, providing a demographic description of the population by age and sex.

All variables were weighted to better align each individual case with the distributions of age, sex and metropolitan or rural/regional location for the total population.

In this study, we report the findings from one survey question relating to the type of AD completed by respondents. Four legal ADs are recognised in SA — enduring power of attorney (EPA), enduring power of guardianship (EPG), medical power of attorney (MPA) and anticipatory direction.

To clarify the specific documents in question, an introductory statement about ADs in general and a brief definition of each AD was provided to participants at the interview stage (Appendix 1). We used the term “living will” instead of anticipatory direction in this introductory statement as the living will has had more consistent use in the literature and by the public.1,2 However, for the purposes of this report, we use anticipatory direction to mean any type of living will document rather than it being limited to medical decisions about end of life.

The study was approved by the Flinders University Social and Behavioural Research Ethics Committee (Project No. 5748).

Statistical analysis

Data were analysed using SPSS version 19 (IBM SPSS Statistics). All analyses were performed using weighted data, and only weighted results are reported unless otherwise specified. Univariate analysis of individual AD document completion with demographic information was performed using χ2 tests of association. A multivariate binary logistic regression was used to assess the independent associations between non-completion of any of the documents and demographic variables. All demographic variables were included in the multivariate model regardless of their statistical significance. Associations for which a two-tailed P value of < 0.05 were obtained were considered statistically significant.

Results

Frequency of document completion

From the 5063 households contacted, 3055 interviews were completed, representing a 60.3% response rate and a 64.4% participation rate (Appendix 2). Wills were the most commonly reported completed instruments (48%), even though they are not ADs. For the recognised legal ADs in SA, more respondents reported having completed the EPA (22%) than any of the health care-related documents — EPG (13%), MPA (11%), anticipatory direction (12%) (Appendix 3).

Individual document completion

Appendix 3 shows that there was an inverse association between rates of completion of individual documents and age across all documents, with those aged 65 years and older showing a much higher completion rate than those in the youngest age category of 15–24 years. People who were married or widowed were more likely to have completed the financial documents — EPA (29% married and 54% widowed) and a will (65% married and 81% widowed) — compared with those who had never married, or who had separated or divorced (EPA, 4% never married and 10% separated/divorced; will, 11% never married and 27% separated/divorced; < 0.001 for each). There was no difference between the sexes in completion rates of documents, or between metropolitan and rural/regional respondents, except for the EPA and will where the frequency of rural/regional respondent completion rates was slightly higher than that for metropolitan respondents (EPA, 26% rural/regional v 20% metropolitan; P = 0.002, and will, 53% rural v 47% metropolitan; P = 0.004). Those still studying at school or elsewhere had the lowest percentage of completion of documents compared with those with other education levels. Those in the “never worked, student, home duties” category had the lowest percentage compared with those earning an income (results not shown).

Non-completion of any documents

The Box shows the results of the multivariate binary logistic regression for the reported non-completion of any documents. Non-completion rates for any of the four types of AD documents were significantly and independently associated with age (P < 0.001), area of residence (P = 0.031), country of birth (P < 0.001), marital status (P < 0.001), education level (P = 0.003), occupation (P = 0.001) and annual income (P < 0.001).

Discussion

Our findings show for the first time that, although completion rates remain highest in the 65 years and older age group, there is still a significant proportion of older people not completing health care ADs. Older people may not be aware that these documents exist, may not accept their role and value, or may choose not to complete them. Some older people may assume or prefer that health professionals will initiate discussions around these documents at the appropriate time.5

It is interesting and encouraging that younger people (aged 45–64 years) seem to be completing ADs. GPs and other health care professionals are likely to have increasing and ongoing patient encounters with generational groups like the baby boomers (born 1946–1965) as they age. Providing an opportunity to discuss ADs with those aged 45 years and over can facilitate completion of ADs at a time when patients are in relatively good health, as well as build an understanding of factors that may influence health care decision making for them in the future.

While anyone aged over 18 years can complete an AD in SA, those aged 18 to 45 years are far less likely to complete these documents. Targeted health promotion in this group similar to the recent organ donation campaign could increase awareness and promote the benefits of completed ADs in the event of a health care crisis in the future.

The documents most often reported as completed by the general public were a will and, of the four formal ADs in SA, the EPA, a financial instrument, rather than the health care instruments EPG, MPA and anticipatory direction or living will. The relatively high completion rate of EPAs and wills indicates that taking care of our financial assets is an accepted responsibility for many in the community. This could provide a useful context for encouraging people to complete other life-planning documents when GPs are made aware of life-plan changes for a patient (eg, admission to residential aged care, retirement or travelling overseas or interstate). Being open to discussing ADs at this time may provide future benefits to patients, health care practitioners, and families if a future health care crisis occurs.

Given that rural and regional area of residence and non-married or non-working status were each associated with reduced odds of completing most ADs, GPs working in the country or in areas with a high proportion of non-married and non-working individuals might find it especially useful to promote the role of ADs and the value of identifying a trusted substitute decisionmaker to help with future decisions.

While our study has shown that rates of completion of ADs, especially health care and lifestyle ADs, continue to be low, the use of these documents by younger age groups is encouraging and indicates that broadening GP discussion of ADs to include younger age groups might be important in meeting patient goals of future care. Our findings also indicate that those in lower socioeconomic groups may be vulnerable to having their personal autonomy in health care decision making thwarted unless they are given targeted direction on ADs. Detail about the sociodemographic characteristics of those most likely not to have completed ADs provides a useful framework that could help GPs provide these groups with targeted health promotion using relevant community health services.

Analysis of data from the South Australian Health Omnibus Survey Spring 2012 showing the prevalence and independent odds of the 3055 respondents not completing any advance directive documents*

Demographic characteristic

No. not completing
documents

Percentage of total (95% CI)

Odds ratio (95% CI)

P


Age (years)

       

15–24

451

93% (90%–95%)

55.3 (31.3–97.7)

< 0.001

25–44

670

69% (66%–72%)

24.9 (17.3–36.1)

< 0.001

45–64

270

27% (24%–30%)

4.4 (3.2–6.3)

< 0.001

≥ 65

60

10% (8%–12%)

1.0

 

Area of residence

       

Metropolitan

1097

49% (47%–51%)

1.0

 

Rural/regional

354

43% (40%–47%)

0.8 (0.6–1.0)

0.031

Country of birth

       

Australia

1055

47% (44%–49%)

1.0

 

Other

396

50% (47%–54%)

2.0 (1.6–2.4)

< 0.001

Marital status

       

Married

483

31% (28%–33%)

1.0

 

De facto

225

68% (63%–73%)

2.8 (2.1–3.8)

< 0.001

Separated/divorced

109

42% (36%–48%)

1.8 (1.3–2.4)

0.001

Widowed

24

14% (9%–19%)

1 (0.6–1.7)

0.993

Never married

609

86% (83%–88%)

3.1 (2.3–4.2)

< 0.001

Education level

       

Left school in Year 12 or before

372

40% (37%–43%)

1.5 (1.1–1.9)

0.003

Still studying at school or elsewhere

277

85% (81%–89%)

1.2 (0.7–2.0)

0.574

Trade/apprenticeship, certificate/diploma

467

42% (39%–45%)

1.0

 

Bachelor degree or higher

335

49% (45%–53%)

1.5 (1.1–2.0)

0.005

Occupation

       

Professional

410

43% (40%–46%)

1.0

 

Clerical and sales

315

38% (35%–42%)

1.02 (0.0.8–1.3)

0.879

Blue collar

446

49% (46%–52%)

1.6 (1.3–2.2)

0.001

Never worked, student, home duties

146

69% (63%–76%)

2.2 (1.4–3.6)

0.001

Annual income

       

0–$40 000

210

36% (32%–40%)

1.2 (0.9–1.7)

0.208

$40 001–$80 000

294

51% (46%–55%)

1.0

 

≥ $80 001

397

42% (39%–45%)

0.6 (0.5–0.8)

< 0.001

Not stated

550

58% (55%–61%)

0.8 (0.6–1.1)

0.227


* Multivariate binary logistic regression analysis; numbers and percentages may not add to totals or 100% as data are weighted and rounded to whole decimals. † Australian and New Zealand Standard Classification of Occupations codes.4

Palliative Care

Palliative Care Australia is seeking feedback on its latest draft of industry standards.

PCA President Professor Patsy Yates said the process had been driven by the palliative care sector, which was calling for the standards to be updated to “clearly articulate and promote a vision for compassionate and appropriate end of life care across all settings”.

Australia’s ageing population will place increasingly heavy demand on the palliative care sector in the coming years. The industry body is aiming to ensure the standards reflect current practice while remaining relevant in the future.

Individuals and groups can offer their contributions on National Palliative Care Australia website until 26 September 2014.

 

Palliative Care

Palliative Care Australia is seeking feedback on its latest draft of industry standards.

PCA President Professor Patsy Yates said the process had been driven by the palliative care sector, which was calling for the standards to be updated to “clearly articulate and promote a vision for compassionate and appropriate end of life care across all settings”.

Australia’s ageing population will place increasingly heavy demand on the palliative care sector in the coming years. The industry body is aiming to ensure the standards reflect current practice while remaining relevant in the future.

Individuals and groups can offer their contributions on National Palliative Care Australia website until 26 September 2014.

 

Palliative Care

Palliative Care Australia is seeking feedback on its latest draft of industry standards.

PCA President Professor Patsy Yates said the process had been driven by the palliative care sector, which was calling for the standards to be updated to “clearly articulate and promote a vision for compassionate and appropriate end of life care across all settings”.

Australia’s ageing population will place increasingly heavy demand on the palliative care sector in the coming years. The industry body is aiming to ensure the standards reflect current practice while remaining relevant in the future.

Individuals and groups can offer their contributions on National Palliative Care Australia website until 26 September 2014.

 

First-ever nationwide palliative care survey

GPs have been asked to participate in the first-ever attempt to identify and map the availability of palliative and advance care planning services nationwide.

A survey being conducted by a consortium of leading national health, academic and aged care organisations aims to tap into the local knowledge of GPs to provide an accurate picture of the palliative and advance care planning services available in each area.

The information collected will be used to help fill service gaps around the country, and to develop a dedicated 24 hour hotline to provide specialist palliative care and advance care planning advice.

GPs who decide to take part are asked to complete online survey of existing palliative care and advance care planning arrangements in their practice. Completing the survey is expected to take around 15 minutes.

Project leader, Associate Professor Bill Silvester, said the survey seeks to capture the knowledge of GPs, so that an accurate picture of services can be obtained.

“GPs and managers of aged care services have a good understanding of the palliative care and advance care planning services currently available in their local area, so it is really important that as many as possible participate in the survey, because the results will determine how program resources can be targeted to those in most need,” Associate Professor Silvester said.

Findings from the survey will be incorporated into the first-ever national scan of the sector, with the information used to develop a suite of programs under the Specialist Palliative Care and Advance Care Planning Advisory Services Project.

These will include the 24 hour hotline, as well as education, training and web-based resources for health and aged care professionals to enhance their skills in palliative care and advance care planning.

To participate in the survey, go to https://www.surveymonkey.com/s/GeneralPractitioner1

The survey closes on Friday, 23 May.

For more information about the survey or the Advisory Services Project, contact Palliative Care Australia on 02 6232 4433.

 

Let us decide when and how to die, say older Australians

A large majority of older people want the right to control the circumstances and timing of their death, and can envisage a situation in which they would seek help to end their life, a survey has found.

But, suggesting that talking about death remains a taboo topic for many, almost 36 per cent of 1804 people aged 50 years and older surveyed by the Council on the Ageing (COTA) NSW admitted they had not discussed their end-of-life care wishes with anyone.
Encouragingly, the online survey found that an overwhelming majority of older people (85 per cent) judged themselves to be in good or excellent health, while just two per cent rated their health as poor.

As part of the study, participants were asked about access to health care, and almost 80 per cent reported driving to see their GP, highlighting concerns about the health implications for the elderly if they lose their driver’s licence.
Reflecting this, 20 per cent said better public transport was needed in order to improve access to their GP, while more than 43 per cent thought there should be greater co-location of health services.

Among older people, consistency in GP care was rated highly – more than 40 per cent said the most important aspect of GP visits was seeing the same doctor every time. A further 22 per cent thought having their diagnosis and treatment explained so that they could manage their recovery was most important, while 19 per cent rated prompt service most highly.

When it came to hospital treatment, almost 50 per cent of those surveyed considered that having their diagnosis and treatment explained so that they could manage their recovery was most important, while almost 34 per cent set highest store on being treated with dignity and respect.
In a sign of unease among many about current arrangements, more than a quarter felt palliative care did not provide a comfortable end to life.
Of those who had discussed their end-of-life wishes with others, 64 per cent reported they had had such a conversation with their partner or carer, 58 per cent said they had discussed it with their children, 34 per cent had talked about it with friends, 22.6 per cent had discussed it with their GP and 20.6 per cent had had the conversation with their lawyer.

Most commonly (55 per cent), people wanted to die at home, while 12 per cent wanted to pass away in hospital, and many (26 per cent) remained unsure.
What was clear was that most (76.8 per cent) wanted the right to decide where and when they would die, including the possibility that they might be assisted in ending their life.

It is the latest survey suggesting that there is considerable support in the community for euthanasia laws.
COTA NSW said the survey showed that “older Australians are willing and able to take a high level of control over their lives, including the final phase of their lives”.

Adrian Rollins

Here

there is something comforting about sitting here with my hand on Robert’s breast

he says, here, steady yourself against me here, he says, after a pause, he is thinking how best

to fit me, he says it must have been bad but you’re here, you’re with us

the surroundings burst with surgical fittings

it all looks very Weimar, very neue Sach

i expect fishnets, a crossed leg, a trail of cigar smoke somewhere

but there is only Robert and me and all the boxes

and Robert saying again, here, steady yourself against me here

Take your time

Without the accoutrements of fame, American actress Angelina Jolie would be just one of many young women who are using genetic knowledge to manage their breast and ovarian cancer risk. However, with her unavoidable celebrity, Jolie’s explanation of her preventive double mastectomy, and possible later oophorectomy, to reduce the risk associated with a BRCA1 mutation (http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html) has again brought breast and ovarian cancer to public attention.

In its essentials, Jolie’s story is an exercise in the clinical management of genetic information to better one’s future health. In such situations, both doctors and patients need time (an often scarce commodity) to negotiate the complex pathway from knowledge to clinical action, as our understanding of diseases and their associations becomes more intricate, but is still incomplete.

Despite the cultural power of a famous actress’s real-life story in creating positive effects on health behaviour in society, the complexities of clinical interpretation and practice — and how they affect patients’ decisions — can be unintentionally sidelined in public discussion. Following the surge of media interest in Jolie’s announcement, referrals to two familial cancer centres in Victoria almost immediately doubled, according to James and colleagues (doi: 10.5694/mja13.11218). Many of these people had family histories suggesting carriage of a relevant mutation, and among them were probably people at risk who may not otherwise have presented for genetic testing and counselling. Some good may indeed have come from the burst of publicity. But the complex discussion and decision making involved — requiring a concurrent understanding of disease risk, genetics and oncogenesis, and its nuanced application to an individual’s circumstances — likely caught many of those presenting to the clinics off guard. Among women with known BRCA1 and BRCA2 mutations, there is currently quite low uptake of preventive options, as research presented by Collins and colleagues (doi: 10.5694/mja13.10848) shows. They propose reasons for this, but it is uncertain what proportion of women not undertaking preventive measures make a fully informed decision not to act, and what proportion are not treated because of an unintended gap in care.

With continuing advances in the field, it is timely to discuss the current application of germline genetics to cancer more generally. Winship and Tucker (doi: 10.5694/mja13.10978) provide an overview of our genetic knowledge about many cancers, and its interpretation and application to clinical decisions, which is now mature enough to be part of routine care. Informed patient counselling requires significant investment of time and effort. Current and future developments, especially in genomics and next-generation genetic sequencing, bring ethical and social challenges as well as clinical ones. The old idea that genes would provide clear answers has certainly gone.

Other clinical problems also demonstrate the intersection of incomplete knowledge, problems in diagnostic capability and interpretation, and imperatives to act on the information we have. In a letter to the Editor, MacLachlan and Cowie (doi: 10.5694/mja13.10478) propose that low vitamin D levels increase the likelihood of reactivation of tuberculosis (TB), citing the coincident seasonality of active TB cases and vitamin D deficiency. They advocate vitamin D testing and supplementation in groups at high risk. In an editorial, Truswell (doi: 10.5694/mja13.11121) outlines plausible physiological reasons for this observation, which may explain the use of sunshine and cod liver oil for treating patients with TB in the sanatoria of old. But, as Ralph and Lucas argue (doi: 10.5694/mja13.11174), many questions remain unanswered about accurate vitamin D testing and interpretation, the benefits of supplementation, and potential harms of oversupplementation. Should we wait for a large-scale randomised controlled trial examining the effects on TB of treating vitamin D deficiency to make a public health recommendation? Or can we act on less definitive evidence and, if so, what level of evidence should that be?

Proper planning for a “good death” for those with increasingly debilitating chronic illness needs to be calm, careful and mindful of the patient’s relationships, values and specific wishes, and not devised “on the fly” in a health crisis. Sadly, the reality is that in many cases timely planning does not take place. Scott and colleagues outline the many positive clinical and psychological benefits of advance care planning, and ways to overcome obstacles (doi: 10.5694/mja13.10158). Clinicians should be given proper opportunity to develop advance care plans with patients; even a little more time out of a busy schedule would go a long way. For the community to accept that everyone should allow for such planning as an essential part of their later years, perhaps we now need celebrities to publicly and articulately talk about their own advance care plans. Ultimately, we all need to realise the supreme importance of time, not only for advance care planning, but also for wellbeing — time to discover, time to think, time to talk, time to act.

Subacute care funding in the firing line

Recent enhancements to subacute care services are threatened due to the uncertain future of federal–state funding agreements

The term “subacute” was coined for use in Australia 21 years ago to describe health care where the patient’s need for care is driven predominantly by his or her functional status rather than principal diagnosis.1 Subacute care includes rehabilitation, palliative care, geriatric evaluation and management, and psychogeriatrics. Rehabilitation represents more than 50% of all subacute hospital care in Australia.2

The past two decades have seen slow growth in subacute care. However, the public sector was given substantial momentum in recent years through two National Partnership Agreements (NPAs) between the federal government and the state and territory governments, negotiated by the Council of Australian Governments (COAG) — the Hospital and Health Workforce Reform (HHWR) NPA and the Improving Public Hospital Services (IPHS) NPA. Both NPAs aimed to “improve efficiency and capacity in public hospitals”.3

The 5-year HHWR NPA was signed in 2008 and, of the total funding of $3042 million negotiated under this agreement, $1383 million was provided by the federal government to the states and territories. This consisted of $133.41 million for activity-based funding (ABF) infrastructure, $500 million for subacute services, and $750 million for “taking the pressure off public hospitals” by addressing waiting lists and times.3 The $500 million allocated for subacute services was provided in one instalment, with its distribution to all states and territories based on age-weighted population.

The IPHS NPA was signed in 2011.4 It consisted of total funding of $3373 million, including up to $1623 million for new subacute beds. This was allocated over 4 financial years — $233.6 million in 2010–11, $317.6 million in 2011–12, $446.5 million in 2012–13, and $625.5 million in 2013–14.

Box 1 shows that activity increases in subacute services attributable to the HHWR NPA occurred in all states and territories. More than 600 000 extra bed-day equivalents (inpatient days plus ambulatory care equivalents) were provided in 2011–12 than in the baseline year of 2007–08, representing 25.9% growth across Australia.5 The target in the HHWR agreement was a 5% increase in each of the 4 years — this was exceeded by the end of Year 3 (2011–12).

The 2009 report of the National Health and Hospitals Reform Commission (NHHRC) stated that:

There is … an urgent need for substantial investment in, and expansion of, sub-acute services — the ‘missing link’ in care — including a major capital boost to build the facilities required.

It also recommended the introduction of clear targets to increase the provision of subacute services, and stated that “Incentive funding under the National Partnership Payments could be used to drive this expansion in sub-acute services”.6

The NHHRC recommended investment beyond the targeted 5% increase per year under the HHWR agreement, recognising that much of this 5% increase would only account for extra demand associated with population ageing and growth. Indeed, as shown in Box 1, most states and territories have delivered much greater than 5% growth, with South Australia and Queensland reporting increases of 50% and 43%, respectively.5

The HHWR agreement made provision for a review of progress “in respect of achieving the agreed outcomes”, to occur in July 2011.3 However, apart from the annual reports of the states and territories describing the services developed under the NPA, and the reporting of activity measures, there is no evidence that any review of the NPA on a national basis has occurred. Further, although the NPA specifically describes the role of the federal government as including provision of funding support for “research into best practice models of care” and funding and providing “national coordination of the initiative [and] monitor[ing] performance”,3 no provision was made for funding to continue beyond the term of the NPA, nor for a formal evaluation of outcomes at its conclusion. Consequently, the effectiveness of the developed services cannot be fully assessed because they have not been subjected to rigorous evaluation. Although formal outcomes cannot be reported, examples of rehabilitation programs funded by the HHWR agreement are given in Box 2.

In contrast, the IPHS agreement specifies that an evaluation framework will be developed and that a review of the agreement will be completed, with a decision by COAG by December 20134 — although no details have been released to date.

These two agreements have provided public hospitals with unprecedented opportunities to develop new inpatient and ambulatory rehabilitation services and to expand existing services. These new and expanded services have dealt with previously identified deficiencies, especially the need for early rehabilitation in the acute care setting and increasing the intensity of therapy within rehabilitation settings.810 Public hospitals have been able to develop better rehabilitation capital infrastructure and better meet the growing need for rehabilitation, particularly among the ageing population. Between them, these two agreements represented a turning point in the development of public sector rehabilitation services across the country.

There is growing international evidence showing improved patient outcomes from the provision of more intense therapy (ie, therapy “dose”) in the rehabilitation setting, as well as showing improved efficiency.8,9,11 In the United States, where therapy of 3 hours per day for a minimum of 5 days per week is mandated in inpatient rehabilitation,9 length of stay for patients undergoing stroke rehabilitation is shorter, and the rate of attainment of functional gain is higher, than in Australia.12

More intense therapy should result in more efficient use of rehabilitation beds if length of stay can be reduced as a result. This is because the cost of providing extra therapy is relatively low compared with the high fixed costs of running an inpatient bed.

With the HHWR NPA ending on 30 June 2013, many of these new and expanded rehabilitation programs will cease. Staff are already seeking alternative employment, and programs are beginning to wind down. The fact that many health services across the country will now be closing down rehabilitation and other subacute initiatives that were funded under this NPA suggests a lack of planning by the federal, state and territory governments for what would happen after the HHWR NPA ends.

Development of subacute care must continue if Australia is to keep pressure off the acute hospital system and deal effectively with population ageing. However, in our opinion, the lack of requirements for rigorous evaluation of services developed with HHWR NPA funding, which could have provided a basis for ongoing funding if the requirements were met, is not justifiable.

Even if these programs demonstrate system-wide efficiency gains, this does not free up resources; rather, it increases capacity. As such, it would be difficult for state and territory governments to continue to fund successful programs out of existing resources, unless other programs were cut. The new ABF arrangements are not sufficient to pick up where the HHWR agreement has left off, not least because federal growth funding does not begin until 2014–15.13

At the system level, the sudden closure of rehabilitation and other subacute services will have flow-on effects to the acute care system, as it will increasingly have to manage patients who would otherwise have been referred to rehabilitation. The net effect is likely to be that the length of stay in acute care will increase, along with bed occupancy and waiting times.

1 Reported increase in subacute care services under the National Partnership Agreement on Hospital and Health Workforce Reform, by state and territory*

Jurisdiction

Services in 2007–08 (baseline)

Services in 2011–12

Increase (%) in 2011–12 compared with baseline


New South Wales

679 048

813 283

134 235 (19.8%)

Victoria

786 648

933 930

147 282 (18.7%)

Queensland

290 368

414 531

124 163 (42.8%)

South Australia

197 583

296 604

99 021 (50.1%)

Western Australia

511 498

658 781

147 283 (28.8%)

Tasmania

46 815

56 243

9 428 (20.1%)

Australian Capital Territory

62 745

68 038

5 293 (8.4%)

Northern Territory

11 227

14 261

3 034 (27.0%)

All

2 585 932

3 255 671

669 739 (25.9%)


* Compiled from the individual state and territory government reports submitted to the Steering Committee for the Review of Government Service Provision (for Schedule C of the National Partnership Agreement on Hospital and Health Workforce Reform).5

2 Examples of rehabilitation programs funded by the National Partnership Agreement on Hospital and Health Workforce Reform

  • At St Vincent’s Hospital in Sydney, existing services were enhanced and two new services introduced: rehabilitation in the home, and a mobile rehabilitation team. The latter provides rehabilitation within 3 days of acute admission in parallel with acute care. The program targets young disabled patients for whom there are few community services. Hospital length of stay was reduced and patients avoided inpatient rehabilitation, instead accessing ambulatory programs after discharge.
  • In South Australia, large investments were made in home and day rehabilitation services, including substantial investments in Whyalla, Mt Gambier and Berri. The Women’s and Children’s Hospital in Adelaide is now able to provide multidisciplinary community services, allowing access to community-based rehabilitation for 50 children who have had complex surgery, as well as the establishment of a state-wide hip surveillance program for children with cerebral palsy.
  • The South Eastern Sydney Local Health District (SESLHD), one of the largest health districts in New South Wales, focused on increasing intensity of therapy in inpatient rehabilitation and developed acute rehabilitation teams in acute hospitals. The SESLHD has evaluated the outcomes of its enhanced rehabilitation services and reports a 13% reduction in the average length of stay, improved speed of functional gain, and more than 130 avoided rehabilitation admissions annually.7